| Skin and Soft Tissue Infection |
0 |
0.92 |
| Child |
0 |
0.89 |
| Acne |
0 |
0.85 |
| Otolaryngology |
0 |
0.69 |
| Pediatric Dermatology |
0 |
1 |
| Obesity |
0 |
0.47 |
| California |
0 |
0.34 |
| Adolescent Medicine |
0 |
0.99 |
| Gluteal Region |
0 |
0.21 |
| Hospital |
0 |
0.21 |
| Abscess |
0 |
0.17 |
| Acne Conglobata |
0 |
0.17 |
| Inguinal Region |
0 |
0.17 |
| Epidermal Inclusion Cyst |
0 |
0.13 |
| MRSA |
0 |
0.12 |
| Nodule |
0 |
0.09 |
| Sinus |
0 |
0.09 |
| Antibiotics |
0 |
0.07 |
| Bacterial Skin Infection |
0 |
0.06 |
| Topical Corticosteroid |
0 |
0.06 |
| Antibacterial Agents |
0 |
0.04 |
| Bacteria |
0 |
0.04 |
| Cellulitis |
0 |
0.04 |
| Corticosteroids |
0 |
0.04 |
| Dorsum |
0 |
0.04 |
| Face |
0 |
0.04 |
| Femoral |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Gland |
0 |
0.04 |
| Hair |
0 |
0.04 |
| Hidradenitis Suppurativa |
0 |
0.97 |
| Impairment |
0 |
0.04 |
| Patient History |
0 |
0.04 |
| Puberty |
0 |
0.04 |
| Quality of Life |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Refractory |
0 |
0.04 |
| Remission |
0 |
0.04 |
| Staphylococcal Infection |
0 |
0.04 |
| Staphylococcus Aureus Infection |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Topical Antibiotics |
0 |
0.04 |
| Topical Therapy |
0 |
0.04 |
| Tumor |
0 |
0.04 |